Both the nature of KIR3DL1 alleles and the KIR3DL1/S1 allele combination affect the KIR3DL1 NK-cell repertoire in the French population

European Journal of Immunology

Volumn 43, Issue 4, 2013, Pages 1085-1098

  Gagne, Katia ^a,b   Willem, Catherine ^a   Legrand, Nolwenn ^a   Djaoud, Zakia ^a   David, Gaëlle ^a   Rettman, Pauline ^a   Bressollette Bodin, Céline ^a   Senitzer, David ^c   Esbelin, Julie ^d   Cesbron Gautier, Anne ^b   Schneider, Thierry ^a   Retière, Christelle ^a  

^a UNIVERSITÉ DE NANTES   (France)

^b ETABLISSEMENT FRANÇAIS DU SANG   (France)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^d Hopital Mere Enfant CHU de Nantes   (France)

Author keywords

Allelic polymorphism; French population; KIR3DL1; KIR3DL1 S1 allele combinations; NK cell repertoire

Indexed keywords

HLA ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL1;

ADULT; ARTICLE; CELL FUNCTION; CELLULAR DISTRIBUTION; FRANCE; GENE; GENE AMPLIFICATION; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NATURAL KILLER CELL; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ALLELES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FRANCE; GENE FREQUENCY; HUMANS; KILLER CELLS, NATURAL; PHENOTYPE; RECEPTORS, KIR3DL1; RECEPTORS, KIR3DS1;

EID: 84876439240     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201243007     Document Type: Article

References (55)

1. Vivier, E., Raulet, D. H., Moretta, A., Caligiuri, M. A., Zitvogel, L., Lanier, L. L., Yokoyama, W. M. et al., Innate or adaptive immunity? The example of natural killer cells. Science. 2011. 331: 44-49.
2. Parham, P., MHC class I molecules and KIRs in human history, health and survival. Nat. Rev. Immunol. 2005. 5: 201-214.
3. Stern, M., Ruggeri, L., Capanni, M., Mancusi, A. and Velardi, A., Human leukocyte antigens A23, A24, and A32 but not A25 are ligands for KIR3DL1. Blood. 2008. 112: 708-710.
4. Anfossi, N., André, P., Guia, S., Falk, C. S., Roetynck, S., Stewart, C. A., Breso, V. et al., Human NK cell education by inhibitory receptors for MHC class I. Immunity. 2006. 25: 331-342.
5. Morvan, M., David, G., Sebille, V., Perrin, A., Gagne, K., Willem, C., Kerdudou, N. et al., Autologous and allogeneic HLA KIR ligand environments and activating KIR control KIR NK-cell functions. Eur. J. Immunol. 2008. 38: 3474-3486.
6. Trundley, A., Frebel, H., Jones, D., Chang, C. and Trowsdale, J., Allelic expression patterns of KIR3DS1 and 3DL1 using the Z27 and DX9 antibodies. Eur. J. Immunol. 2007. 37: 780-787.
7. O'Connor, G. M., Guinan, K. J., Cunningham, R. T., Middleton, D., Parham, P. and Gardiner, C. M., Functional polymorphism of the KIR3DL1/S1 receptor on human NK cells. J. Immunol. 2007. 178: 235-241.
8. Gillespie, G. M., Bashirova, A., Dong, T., McVicar, D. W., Rowland-Jones, S. L. and Carrington, M., Lack of KIR3DS1 binding to MHC class I Bw4 tetramers in complex with CD8+ T cell epitopes. AIDS Res. Hum. Retroviruses 2007. 23: 451-455.
9. Morvan, M., Willem, C., Gagne, K., Kerdudou, N., David, G., Sebille, V., Follea, G. et al., Phenotypic and functional analyses of KIR3DL1+ and KIR3DS1 +NK cell subsets demonstrate differential regulation by Bw4 molecules and induced KIR3DS1 expression on stimulated NK cells. J. Immunol. 2009. 182: 6727-6735.
10. Single, R. M., Martin, M. P., Meyer, D., Gao, X. and Carrington, M., Methods for assessing gene content diversity of KIR with examples from a global set of populations. Immunogenetics 2008. 60: 711-725.
11. Middleton D, Williams, F. and Halfpenny, I. A., KIR genes. Transpl. Immunol. 2005. 14 135-142.
12. Denis, L., Sivula, J., Gourraud, P. A., Kerdudou, N., Chout, R., Ricard, C., Moisan, J. P. et al., Genetic diversity of KIR natural killer cell markers in populations from France, Guadeloupe, Finland, Senegal and Reunion. Tissue Antigens 2005. 66: 267-276.
13. Uhrberg, M., Valiante, N. M., Shum, B. P., Shilling, H. G., Lienert-Weidenbach, K., Corliss, B., Tyan, D. et al., Human diversity in killer cell inhibitory receptor genes. Immunity 1997. 7: 753-763.
14. Uhrberg, M., The KIR gene family: life in the fast lane of evolution. Eur. J. Immunol. 2005. 35: 10-15.
15. Robinson, J., Mistry, K., McWilliam, H., Lopez, R. and Marsh, S. G., IPD-the Immuno Polymorphism Database. Nucleic Acids Res. 2010. 38(Database issue): D863-869.
16. Parham, P., Norman, P. J., Abi-Rached, L. and Guethlein, L. A., Variable NK cell receptors exemplified by human KIR3DL1/S1. J. Immunol. 2011. 187: 11-19.
17. Norman, P. J., Abi-Rached, L., Gendzekhadze, K., Korbel, D., Gleimer, M., Rowley, D., Bruno, D. et al., Unusual selection on the KIR3DL1/S1 natural killer cell receptor in Africans. Nat. Genet. 2007. 39: 1092-1099.
18. Gumperz, J. E., Valiante, N. M., Parham, P., Lanier, L. L. and Tyan, D., Heterogeneous phenotypes of expression of the NKB1 natural killer cell class I receptor among individuals of different human histocompatibility leukocyte antigens types appear genetically regulated, but not linked to major histocompatibililty complex haplotype. J. Exp. Med. 1996. 183: 1817-1827.
19. Gardiner, C. M., Guethlein, L. A., Shilling, H. G., Pando, M., Carr, W. H., Rajalingam, R., Vilches, C. et al., Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism. J. Immunol. 2001. 166: 2992-3001.
20. Gardiner, C. M., Killer cell immunoglobulin-like receptors on NK cells: the how, where and why. Int. J. Immunogenet. 2008. 35: 1-8.
21. Kim, S., Sunwoo, J. B., Yang, L., Choi, T., Song, Y. J., French, A. R., Vlahiotis, A. et al., HLA alleles determine differences in human natural killer cell responsiveness and potency. Proc. Natl. Acad. Sci. USA 2008. 105: 3053-3058.
22. Stewart, C. A., Van Bergen, J. and Trowsdale, J., Different and divergent regulation of the KIR2DL4 and KIR3DL1 promoters. J. Immunol. 2003. 170: 6073-6081.
23. Chan, H. W., Kurago, Z. B., Stewart, C. A., Wilson, M. J., Martin, M. P., Mace, B. E., Carrington, M. et al., DNA methylation maintains allele-specific KIR gene expression in human natural killer cells. J. Exp. Med. 2003. 197: 245-255.
24. Thananchai, H., Gillespie, G., Martin, M. P., Bashirova, A., Yawata, N., Yawata, M., Easterbrook, P. et al., Cutting Edge: Allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B. J. Immunol. 2007. 178: 33-37.
25. Boulet, S., Song, R., Kamya, P., Bruneau, J., Shoukry, N. H., Tsoukas, C. M. and Bernard, N. F., HIV protective KIR3DL1 and HLA-B genotypes influence NK cell function following stimulation with HLA-devoid cells. J. Immunol. 2010. 184: 2057-2064.
26. Stewart-Jones, G. B., di Gleria, K., Kollnberger, S., McMichael, A. J., Jones, E. Y. and Bowness, P., Crystal structures and KIR3DL1 recognition of three immunodominant viral peptides complexed to HLA-B*2705. Eur. J. Immunol. 2005. 35: 341-351.
27. Carr, W. H., Pando, M. J. and Parham, P., KIR3DL1 polymorphisms that affect NK cell inhibition by HLA-Bw4 ligand. J. Immunol. 2005. 175: 5222-5229.
28. Foley, B. A., De Santis, D., Van Beelen, E., Lathbury, L. J., Christiansen, F. T. and Witt, C. S., The reactivity of Bw4+ HLA-B and HLA-A alleles with KIR3DL1: implications for patient and donor suitability for haploidentical stem cell transplantations. Blood. 2008. 112: 435-443.
29. Martin, M. P., Qi, Y., Gao, X., Yamada, E., Martin, J. N., Pereyra, F., Colombo, S. et al., Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat. Genet. 2007. 39: 733-740.
30. Gagne, K., Busson, M., Bignon, J. D., Balère-Appert, M. L., Loiseau, P., Dormoy, A., Dubois, V. et al., Donor KIR3DL1/3DS1 gene and recipient Bw4 KIR ligand as prognostic markers for outcome in unrelated hematopoietic stem cell transplantation. Biol. Blood Marrow Transplant. 2009. 15: 1366-1375.
31. Yawata, M., Yawata, N., Draghi, M., Little, A. M., Partheniou, F. and Parham, P., Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function. J. Exp. Med. 2006. 203: 633-645.
32. Thomas, R., Yamada, E., Alter, G., Martin, M. P., Bashirova, A. A., Norman, P. J., Altfeld, M. et al., Novel KIR3DL1 alleles and their expression levels on NK cells: convergent evolution of KIR3DL1 phenotype variation? J. Immunol. 2008. 180: 6743-6750.
33. Halfpenny, I. A., Middleton, D., Barnett, Y. A. and Williams, F., Investigation of killer cell immunoglobulin-like receptor gene diversity: IV. KIR3DL1/S1. Hum. Immunol. 2004. 65: 602-612.
34. Pando, M. J., Gardiner, C. M., Gleimer, M., McQueen, K. L. and Parham, P., The protein made from a common allele of KIR3DL1 (3DL1*004) is poorly expressed at cell surfaces due to substitution at positions 86 in Ig domain 0 and 182 in Ig domain 1. J. Immunol. 2003. 171: 6640-6649.
35. Taner, S. B., Pando, M. J., Roberts, A., Schellekens, J., Marsh, S. G., Malmberg, K. J., Parham, P. et al., Interactions of NK cell receptor KIR3DL1*004 with chaperones and conformation-specific antibody reveal a functional folded state as well as predominant intracellular retention. J. Immunol. 2011. 186: 62-72.
36. O'Connor, G. M., Yamada, E., Rampersaud, A., Thomas, R., Carrington, M. and McVicar, D. W., Analysis of binding of KIR3DS1*014 to HLA suggests distinct evolutionary history of KIR3DS1. J. Immunol. 2011. 187: 2162-2171.
37. Single, R. M., Martin, M. P., Gao, X., Meyer, D., Yeager, M., Kidd, J. R., Kidd, K. K. et al., Global diversity and evidence for coevolution of KIR and HLA. Nat. Genet. 2007. 39: 1114-1119.
38. Diaz-Pena, R., Vidal-Castineira, J. R., Alonso-Arias, R., Suarez-Alvarez, B., Vicario, J. L., Solana, R., Collantes, E. C. et al., Association of the KIR3DS1*013 and KIR3DL1*004 alleles with susceptibility to ankylosing spondylitis. Arthritis Rheum. 2010. 62: 1000-1006.
39. Vely, F., Peyrat, M., Couedel, C., Morcet, J., Halary, F., Davodeau, F., Romagne, F. et al., Regulation of inhibitory and activating killer-cell Ig-like receptor expression occurs in T cells after termination of TCR rearrangements. J. Immunol. 2001. 166: 2487-2494.
40. Li, H., Pascal, V., Martin, M. P., Carrington, M. and Anderson, S. K., Genetic control of variegated KIR gene expression: polymorphisms of the bi-directional KIR3DL1 promoter are associated with distinct frequencies of gene expression. PLoS Genet. 2008. 4: e1000254.
41. Schonberg, K., Sribar, M., Enczmann, J., Fischer, J. C. and Uhrberg, M., Analyses of HLA-C-specific KIR repertoires in donors with group A and B haplotypes suggest a ligand-instructed model of NK cell receptor acquisition. Blood 2011. 117: 98-107.
42. Fischer, J. C., Ottinger, H., Ferencik, S., Sribar, M., Punzel, M., Beelen, D. W., Schwan, M. A. et al., Relevance of C1 and C2 epitopes for hemopoietic stem cell transplantation: role for sequential acquisition of HLA-C-specific inhibitory killer Ig-like receptor. J. Immunol. 2007. 178: 3918-3923.
43. Miller, J. S. and McCullar, V., Human natural killer cells with polyclonal lectin and immunoglobulinlike receptors develop from single hematopoietic stem cells with preferential expression of NKG2A and KIR2DL2/L3/S2. Blood. 2001. 98: 705-713.
44. Schönberg, K., Fischer, J. C., Kögler, G. and Uhrberg, M., Neonatal NK-cell repertoires are functionally, but not structurally, biased toward recognition of self HLA class I. Blood. 2011. 117: 5152-5156.
45. Béziat, V., Dalgard, O., Asselah, T., Halfon, P., Bedossa, P., Boudifa, A., Hervier, B. et al., CMV drives clonal expansion of NKG2C+ NK cells: expressing self-specific KIRs in chronic hepatitis patients. Eur. J. Immunol. 2012. 42: 447-457.
46. Charoudeh, H. N., Terszowski, G., Czaja, K., Gonzalez, A., Schmitter, K. and Stern, M., Modulation of the natural killer cell KIR repertoire by cytomegalovirus infection. Eur. J. Immunol. 2012. 43: 1-8.
47. Foley, B., Cooley, S., Verneris, M. R., Pitt, M., Curtsinger, J., Luo, X., Lopez-Vergès, S. et al., Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function. Blood. 2012. 119: 2665-2674.
48. Björkström, N. K., Svensson, A., Malmberg, K. J., Eriksson, K. and Ljunggren, H. G., Characterization of natural killer cell phenotype and function during recurrent human HSV-2 infection. PLoS One 2011. 6: 1-5.
49. Ballan, W. M., Vu, B. A., Long, B. R., Loo, C. P., Michaëlsson, J., Barbour, J. D., Lanier, L. L. et al., Natural killer cells in perinatally HIV-1-infected children exhibit less degranulation compared to HIV-1-exposed uninfected children and their expression of KIR2DL3, NKG2C, and NKp46 correlates with disease severity. J. Immunol. 2007. 179: 3362-3370.
50. Ravet, S., Scott-Algara, D., Bonnet, E., Tran, H. K., Tran, T., Nguyen, N., Truong, L. X. et al., Distinctive NK-cell receptor repertoires sustain high-level constitutive NK-cell activation in HIV-exposed uninfected individuals. Blood 2007. 109: 4296-4305.
51. Miller, D. D. and Polesky, H. F., A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988. 16: 1215.
52. Sun, J., Gaidulis, L., Miller, M., Goto, R., Rodriguez, R., Forman, S. and Senitzer, D., Development of a multiplex PCR-SSP method for killer-cell immunoglobulin-like receptor genotyping. Tissue Antigens 2004. 64: 462-468.
53. Gagne, K., Brizard, G., Gueglio, B., Milpied, N., Herry, P., Bonneville, F., Cheneau, M. L. et al., Relevance of KIR gene polymorphisms in bone marrow transplantation outcome. Hum. Immunol. 2002. 63: 271-280.
54. Rasmussen, A. M., Smeland, E. B., Erikstein, B. K., Caignault, L. and Funderud, S., A new method for detachment of Dynabeads from positively selected B lymphocytes. J. Immunol. Methods 1992. 146: 195-202.
55. David, G., Morvan, M., Gagne, K., Kerdudou, N., Willem, C., Devys, A., Bonneville, M. et al., Discrimination between the main activating and inhibitory killer cell immunoglobulin-like receptor positive natural killer cell subsets using newly characterized monoclonal antibodies. Immunology 2009. 128: 172-184.